90
|
Synergenz BioScience Inc
gene-based risk testing for lung cancer and chronic obstructive pulmonary disease Gene Based Risk Testing For Lung Cancer And Chronic Obstructive Pulmonary Disease, supplied by Synergenz BioScience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/gene-based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/gene+based+risk+testing+for+lung+cancer+and+chronic+obstructive+pulmonary+disease/pmc06037978-274-21-14 Average 90 stars, based on 1 article reviews
gene-based risk testing for lung cancer and chronic obstructive pulmonary disease - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |